Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.76T | 20.43T | 16.91T | 14.55T | 13.17T | 14.93T | Gross Profit |
4.68T | 4.26T | 3.33T | 2.98T | 2.73T | 3.08T | EBIT |
1.45T | 1.38T | 839.40B | 871.23B | 660.21B | 633.64B | EBITDA |
3.01T | 3.17T | 2.40T | 2.36T | 2.08T | 2.28T | Net Income Common Stockholders |
1.04T | 1.11T | 651.42B | 707.07B | 657.42B | 455.75B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.22T | 5.18T | 4.07T | 3.89T | 3.05T | 2.86T | Total Assets |
31.37T | 29.77T | 24.67T | 23.97T | 21.92T | 20.46T | Total Debt |
0.00 | 10.08T | 7.67T | 8.10T | 7.72T | 7.47T | Net Debt |
-4.96T | 5.13T | 3.86T | 4.43T | 4.96T | 4.80T | Total Liabilities |
18.00T | 16.77T | 13.12T | 13.20T | 12.55T | 12.18T | Stockholders Equity |
13.07T | 12.70T | 11.23T | 10.47T | 9.08T | 8.01T |
Cash Flow | Free Cash Flow | ||||
-221.39B | 138.61B | 1.50T | 1.23T | 521.24B | 378.16B | Operating Cash Flow |
478.88B | 747.28B | 2.13T | 1.68T | 1.07T | 979.41B | Investing Cash Flow |
-962.62B | -867.27B | -678.06B | -376.06B | -796.88B | -619.48B | Financing Cash Flow |
814.79B | 918.65B | -1.47T | -615.72B | -283.98B | -87.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $42.11B | 8.49 | 11.47% | 5.67% | 3.03% | 28.54% | |
75 Outperform | $222.77B | 7.31 | 13.36% | 3.57% | -0.59% | 7.56% | |
74 Outperform | $46.99B | 8.28 | 6.54% | 3.77% | 4.37% | 6.93% | |
74 Outperform | $26.05B | 24.64 | 12.22% | ― | 10.28% | -29.75% | |
72 Outperform | $46.34B | 6.94 | 8.88% | 1.24% | 7.76% | -14.17% | |
65 Neutral | €19.93B | 12.39 | 7.39% | 3.61% | -0.05% | -38.16% | |
53 Neutral | $17.55B | ― | -15.52% | ― | 50.45% | 49.81% |